Histoplasmosis News and Research

RSS
Histoplasmosis is an infectious condition caused by the fungus Histoplasma capsulatum. It is caused when the spores of the fungus are inhaled into the lungs. The lungs are the primary infection site.
ATS publishes clinical guideline on laboratory diagnosis of fungal infections

ATS publishes clinical guideline on laboratory diagnosis of fungal infections

FDA approves treatment for adults with non-radiographic axial spondyloarthritis

FDA approves treatment for adults with non-radiographic axial spondyloarthritis

Using a health information exchange network to enhance disease surveillance

Using a health information exchange network to enhance disease surveillance

Which animal is most likely to spread the latest plague?

Which animal is most likely to spread the latest plague?

Despite availability of life-saving medicaiton, annual deaths due to fungal meningitis are still over 180,000

Despite availability of life-saving medicaiton, annual deaths due to fungal meningitis are still over 180,000

Recent estimates reveal burden of serious fungal diseases in 14 different countries

Recent estimates reveal burden of serious fungal diseases in 14 different countries

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Inflectra (infliximab-dyyb) approved for multiple indications

Inflectra (infliximab-dyyb) approved for multiple indications

New diagnostic criteria can help distinguish malignant cancerous chest cavity masses from histoplasmosis

New diagnostic criteria can help distinguish malignant cancerous chest cavity masses from histoplasmosis

MSD announces EC approval of SIMPONI (golimumab) for treatment of adult patients with nr-axial SpA

MSD announces EC approval of SIMPONI (golimumab) for treatment of adult patients with nr-axial SpA

Switching from Remicade to Inflectra benefits patients with rheumatic diseases

Switching from Remicade to Inflectra benefits patients with rheumatic diseases

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

New device may help collect bed bugs safely and effectively

New device may help collect bed bugs safely and effectively

Hospira announces launch of first biosimilar monoclonal antibody in Europe

Hospira announces launch of first biosimilar monoclonal antibody in Europe

Leading microbiologist warns of killer fungi’s increasing threat

Leading microbiologist warns of killer fungi’s increasing threat

Endemic lung infection compromises lung cancer diagnosis

Endemic lung infection compromises lung cancer diagnosis

FDG-PET technology less accurate in diagnosing lung cancer in regions where infections are common

FDG-PET technology less accurate in diagnosing lung cancer in regions where infections are common

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

UCB announces results from PRECiSE clinical trial of Cimzia in patients with Crohn's disease

UCB announces results from PRECiSE clinical trial of Cimzia in patients with Crohn's disease

FDA approves Cimzia for treatment of adults with active ankylosing spondylitis

FDA approves Cimzia for treatment of adults with active ankylosing spondylitis